price
RC
NYSE · RCUS
Arcus Biosciences, Inc.
Healthcare · Biotechnology
$24.32
Up+$0.56 (+2.30%)
Updated Sep 16, 2026, 4:50 PM
SID Score
5.4/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 2.72B
- P/E ratio
- -7.68
- Dividend yield
- 0.00%
- 52-week range
- $11.30 – $31.74
- Volume
- 1.93M
- Avg. volume
- 1.53M
Price performance
RCUS price history
1M range · 20 trading sessions · Daily adjusted prices
RCUS closed at $24.32 after 20 trading sessions, down 17.59% for the selected period.
- Last close
- $24.32
- Period change
- -17.59%
- Period low
- $24.07
- Period high
- $31.57
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $23.89 | $24.35 | $23.31 | $24.32 | 1.93M |
| Sep 14, 2026 | $24.59 | $24.99 | $24.02 | $24.07 | 1.72M |
| Sep 11, 2026 | $26.50 | $26.58 | $24.315 | $24.59 | 4.28M |
| Sep 10, 2026 | $28.02 | $28.455 | $25.91 | $26.15 | 2.39M |
| Sep 9, 2026 | $28.71 | $29.30 | $28.20 | $28.49 | 1.83M |
| Sep 8, 2026 | $29.21 | $29.50 | $28.79 | $29.06 | 1.36M |
| Sep 4, 2026 | $29.64 | $30.10 | $29.40 | $29.66 | 736.98K |
| Sep 3, 2026 | $29.92 | $30.20 | $29.195 | $30.13 | 681.7K |
| Sep 2, 2026 | $30.17 | $31.47 | $29.32 | $29.85 | 1.23M |
| Sep 1, 2026 | $29.18 | $29.87 | $28.68 | $29.71 | 1.53M |
| Aug 31, 2026 | $28.89 | $29.345 | $28.2274 | $29.28 | 1.11M |
| Aug 28, 2026 | $30.13 | $30.435 | $29.06 | $29.21 | 1.09M |
| Aug 27, 2026 | $30.75 | $31.01 | $30.36 | $30.59 | 806.06K |
| Aug 26, 2026 | $31.34 | $31.455 | $30.30 | $30.76 | 685.58K |
| Aug 25, 2026 | $30.11 | $31.58 | $30.11 | $31.57 | 655.7K |
| Aug 24, 2026 | $30.27 | $30.91 | $29.38 | $30.12 | 1.3M |
| Aug 21, 2026 | $29.89 | $30.56 | $29.74 | $30.34 | 1.06M |
| Aug 20, 2026 | $29.88 | $30.39 | $28.94 | $29.52 | 1.55M |
| Aug 19, 2026 | $30.44 | $31.28 | $30.04 | $30.35 | 1.82M |
| Aug 18, 2026 | $29.23 | $29.8625 | $28.94 | $29.51 | 896.39K |
Latest RCUS news
The latest Smart Investors Daily articles mentioning RCUS.
Stock researchResearch & News · SEC Filings
Loading stock research…